Annual report pursuant to Section 13 and 15(d)

Goodwill and Other Intangible Assets (Tables)

v3.22.1
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Identifiable Intangible Assets Carrying Value

 

          As of December 31, 2021     As of December 31, 2020  
    Life     Carrying     Carrying  
    (Years)     Amount     Amount  
                   
Asuragen acquisition:                      
Thyroid   9     $ 8,519     $ 8,519  
RedPath acquisition:                      
Pancreas test   7       16,141       16,141  
Barrett’s test   9       6,682       6,682  
BioPharma acquisition:                      
Trademarks   10       1,600       1,600  
Customer relationships   8       5,700       5,700  
                       
CLIA Lab   2.3     $ 609     $ 609  
                       
Total         $ 39,251     $ 39,251  
                       
Accumulated Amortization         $ (31,964 )   $ (27,900 )
                       
Net Carrying Value         $ 7,287     $ 11,351  
Schedule of Goodwill Carrying Value

The following table displays a roll forward of the carrying amount of goodwill from January 1, 2020 to December 31, 2021:

 

    Carrying  
    Amount  
Balance as of January 1, 2020   $ 8,433  
Adjustments     -  
Balance as of December 31, 2020   $ 8,433  
Adjustments     -  
Balance as of December 31, 2021   $ 8,433  
Schedule of Future Estimated Amortization Expense

 

2022     2023     2024     2025     2026  
                                     
$ 2,143     $ 1,734     $ 873     $ 873     $ 873